184 related articles for article (PubMed ID: 4168655)
1. Development of thyroidal suppression by triiodothyronine during six months' treatment of thyrotoxicosis with antithyroid drugs.
Alexander WD; Harden RM; Shimmins J; McLarty D; McGill P
J Clin Endocrinol Metab; 1967 Dec; 27(12):1682-9. PubMed ID: 4168655
[No Abstract] [Full Text] [Related]
2. Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.
Silverstein GE; Burke G
Arch Intern Med; 1970 Oct; 126(4):615-20. PubMed ID: 4097002
[No Abstract] [Full Text] [Related]
3. Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis.
Alexander WD; McLarty DG; Robertson J; Shimmins J; Brownlie BE; Harden RM; Patel AR
J Clin Endocrinol Metab; 1970 Apr; 30(4):540-3. PubMed ID: 4190916
[No Abstract] [Full Text] [Related]
4. Thyroidal suppression by triiodothyronine as a guide to duration of treatment of thyrotoxicosis with antithyroid drugs.
Alexander WD; Harden RM; Shimmins J
Lancet; 1966 Nov; 2(7472):1041-4. PubMed ID: 4162502
[No Abstract] [Full Text] [Related]
5. Treatment of thyrotoxicosis based on thyroidal suppressiblity.
Alexander WD; Harden RM; Shimmins J; McLarty D; McGill P
Lancet; 1967 Sep; 2(7518):681-4. PubMed ID: 4167095
[No Abstract] [Full Text] [Related]
6. [Studies on the pituitary-thyroid axis in the drug therapy of hyperthyroidism].
Uchiyama K
Nihon Naibunpi Gakkai Zasshi; 1966 Nov; 42(8):884-99. PubMed ID: 4165941
[No Abstract] [Full Text] [Related]
7. Thyroidal suppressibility after stopping long-term treatment of thyrotoxicosis with anti-thyroid drugs.
Alexander WD; Harden RM; McLarty D; Shimmins J
Metabolism; 1969 Jan; 18(1):58-62. PubMed ID: 4179400
[No Abstract] [Full Text] [Related]
8. Thyroid function after treatment of hyperthyroidism.
Lancet; 1975 Sep; 2(7935):590-1. PubMed ID: 51412
[No Abstract] [Full Text] [Related]
9. [Clinical studies of long-acting thyroid stimulator].
Eguchi Y
Nihon Naibunpi Gakkai Zasshi; 1970 Nov; 46(8):939-52. PubMed ID: 4099204
[No Abstract] [Full Text] [Related]
10. Spectrum of thyroid function in patient's remaining in remission after antithyroid drug therapy for thyrotoxicosis.
Irvine WJ; Gray RS; Toft AD; Seth J; Lidgard GP; Cameron EH
Lancet; 1977 Jul; 2(8030):179-81. PubMed ID: 69792
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of determination of early thyroidal 131-I uptake rate--relationship with 24-hour 131-I uptake rate].
Nagataki S; Uchimura H; Irie M; Tsushima T; Masuyama H
Horumon To Rinsho; 1972 Feb; 20(2):107-14. PubMed ID: 4112484
[No Abstract] [Full Text] [Related]
12. [Treatment of hyperthyroidism in children with antithyroid drugs and the results of T3 inhibition and TRH tests].
Niimi H; Matsumoto S; Kubimura N; Sasaki N; Hoshina K
Horumon To Rinsho; 1974 Oct; 22(10):1153-5. PubMed ID: 4141286
[No Abstract] [Full Text] [Related]
13. Assessment of thyroid function during and after treatment of thyrotoxicosis.
McLarty DG; Alexander WD
J Clin Pathol; 1975 Mar; 28(3):251-4. PubMed ID: 47343
[No Abstract] [Full Text] [Related]
14. Antithyroid drugs.
Cooper DS
N Engl J Med; 2005 Mar; 352(9):905-17. PubMed ID: 15745981
[No Abstract] [Full Text] [Related]
15. The triiodothyronine suppression test in hyperthyroid patients on antithyroid medication.
Friis T
Acta Med Scand; 1965 Nov; 178(5):667-79. PubMed ID: 4158793
[No Abstract] [Full Text] [Related]
16. Thyroid suppression test as index of outcome of hyperthyroidism treated with antithyroid drugs.
Cassidy CE
Metabolism; 1970 Oct; 19(10):745-50. PubMed ID: 4096944
[No Abstract] [Full Text] [Related]
17. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
Buerklin EM; Schimmel M; Utiger RD
J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.
Chopra IJ; Solomon DH; Johnson DE; Chopra U; Fischer DA
J Clin Endocrinol Metab; 1970 Apr; 30(4):524-8. PubMed ID: 5435290
[No Abstract] [Full Text] [Related]
19. Management of thyrotoxicosis in pregnancy. Value of serial protein-bound iodine and hamolski tests.
Kaori M; Itelson I
Isr J Med Sci; 1969; 5(1):43-8. PubMed ID: 4183678
[No Abstract] [Full Text] [Related]
20. [The suppression test in the control of the course of antithyroid drug therapy: renaissance of an in vivo nuclear medicine procedure?].
Reiners C; Becker W; Börner W
Nuklearmedizin; 1985 Jun; 24(3):135-40. PubMed ID: 2414740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
